Technology-enabled Management Versus Usual Care for Blood Pressure
A Two-arm Parallel Randomized Clinical Trial of Implementation of Technology-enabled Management Versus Usual Care for Blood Pressure
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 30 Years to 90 Years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "Efficiency will be assessed based on total time to screen each patient from record access to eligibility determination. * Workload and Satisfaction: Surveys will capture resident and coordinator perceptions of workload, satisfaction, and feasibility of each method, with Likert scales and qualitative feedback (Ellis \& Kasperbauer, 2020)."
- "Representativeness and satisfaction will be evaluated through the analysis of demographic characteristics, including age, race, and gender along with responses to surveys assessing workload and satisfaction."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
Two arm parallel randomized clinical trial
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Official eligibility criteria
Inclusion Criteria: * Age 30-90 yrs. * Smartphone ownership * Office SBP: ≥ 140 mm Hg * ≤ 2 current anti-HTN meds * Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose) * English or Spanish-speakers Exclusion Criteria: * Heart failure with reduced ejection fraction (EF \< 40%) * ESRD (GFR \<15) * Renal replacement therapy * Pregnant * Myocardial infarction or stroke within preceding 6 months * Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months * Prior solid organ transplantation * At the clinical discretion of the investigators * Enrolled in another clinical study
Study sites (3)
CA
- Stanford Health Care · Palo Alto, CA 94305Paul Wang, MD · Study contact · 650-723-9363 · pjwang@stanford.eduMeg Babakhanian, PhD · Study contact · 818-618-4764 · mbabakha@stanford.eduPaul Wang, MD · Principal investigatorMore trials in Palo Alto
GA
- Morehouse School of Medicine · Atlanta, GA 30310Wendi Wright, MD · Study contact · 470-681-4239 · wewright@msm.eduMelvin Echols, MD · Principal investigatorMore trials in Atlanta
- Lake Country Medical Group · Eatonton, GA 31024Nicolas Chronos, MD · Study contact · 706-485-4004 · drchronos@cardiologycareclinics.comAsher Miller, BS · Study contact · 404-731-5467 · asher.miller@cardiologycareclinics.comNicolas Chronos, MD · Principal investigatorMore trials in Eatonton